Molecular mechanisms underlying anticancer effects of myricetin

Life Sciences

Volumn 142, Issue , 2015, Pages 19-25

  Devi, Kasi Pandima ^a   Rajavel, Tamilselvam ^a   Habtemariam, Solomon ^b   Nabavi, Seyed Fazel ^c   Nabavi, Seyed Mohammad ^c  

^a ALAGAPPA UNIVERSITY   (India)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Akt; Ap 1; Apoptosis; Cdk1; Erk1 and Erk2; Jak1; Mek1; Metastasis; Myricetin; Stat3

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE; GELATINASE A; JANUS KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; MYRICETIN; RAF PROTEIN; STAT3 PROTEIN; UROKINASE; FLAVONOID; ONCOPROTEIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL AGING; CELL CYCLE CHECKPOINT; CELL CYCLE M PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL MOTILITY; CELL POLARITY; CELL PROLIFERATION; CELL STRUCTURE; CHEMOPROPHYLAXIS; CHEMOSENSITIVITY; DRUG BIOAVAILABILITY; DRUG DNA BINDING; HUMAN; INTRACELLULAR SIGNALING; IRON CHELATION; METASTASIS; METASTASIS INHIBITION; MICROEMULSION; NONHUMAN; ONCOGENE H RAS; ONCOGENE N RAS; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SENESCENCE; ANIMAL; DRUG EFFECTS; METABOLISM; MITOSIS; NEOPLASMS; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; FLAVONOIDS; HUMANS; MITOSIS; NEOPLASMS; ONCOGENE PROTEINS;

EID: 84944726987     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.10.004     Document Type: Review

References (98)

1. R.W. Ruddon Cancer Biology 2007 Oxford University Press
2. D. Saranath, and A. Khanna Current status of cancer burden: global and Indian scenario Biomed. Res. J. 1 2014 1 5
3. P. Anand, A.B. Kunnumakara, C. Sundaram, K.B. Harikumar, S.T. Tharakan, O.S. Lai, B. Sung, and B.B. Aggarwal Cancer is a preventable disease that requires major lifestyle changes Pharm. Res. 25 2008 2097 2116
4. M. Esteller Epigenetics in cancer N. Engl. J. Med. 358 2008 1148 1159
5. R. Taby, and J.P.J. Issa Cancer epigenetics CA Cancer J. Clin. 60 2010 376 392
6. F.P. Perera Environment and cancer: who are susceptible? Science 278 1997 1068 1073
7. B.N. Ames, L.S. Gold, and W.C. Willett The causes and prevention of cancer Proc. Natl. Acad. Sci. 92 1995 5258 5265
8. P. Boffetta Human cancer from environmental pollutants: the epidemiological evidence Mutat. Res. 608 2006 157 162
9. V. Curti, E. Capelli, F. Boschi, S.F. Nabavi, A.I. Bongiorno, S. Habtemariam, S.M. Nabavi, and M. Daglia Modulation of human miR-17-3p expression by methyl 3-O-methyl gallate as explanation of its in vivo protective activities Mol. Nutr. Food Res. 58 2014 1776 1784
10. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the 30 years from 1981 to 2010 J. Nat. Prod. 75 2012 311 335
11. S. Fulda Modulation of apoptosis by natural products for cancer therapy Planta Med. 76 2010 1075 1079
12. W. Tan, J. Lu, M. Huang, Y. Li, M. Chen, G. Wu, J. Gong, Z. Zhong, Z. Xu, and Y. Dang Anti-cancer natural products isolated from Chinese medicinal herbs Chin. Med. 6 2011 27
13. G.M. Cragg, D.G. Kingston, and D.J. Newman Anticancer agents from natural products 2011 CRC Press
14. A.L. Demain, and P. Vaishnav Natural products for cancer chemotherapy Microb. Biotechnol. 4 2011 687 699
15. R.G. Mehta, G. Murillo, R. Naithani, and X. Peng Cancer chemoprevention by natural products: how far have we come? Pharm. Res. 27 2010 950 961
16. S.M. Nabavi, S.F. Nabavi, S. Eslami, and A.H. Moghaddam In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue Food Chem. 132 2012 931 935
17. S.F. Nabavi, S.M. Nabavi, S. Habtemariam, A.H. Moghaddam, A. Sureda, M. Jafari, and A.M. Latifi Hepatoprotective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress Ind. Crop. Prod. 44 2013 50 55
18. S.M. Nabavi, A. Marchese, M. Izadi, V. Curti, M. Daglia, and S.F. Nabavi Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacy Food Chem. 173 2015 339 347
19. S.F. Nabavi, S.M. Nabavi, W.N. Setzer, S.A. Nabavi, and M.A. Nabavi Ebrahimzadeh, antioxidant and antihemolytic activity of lipid-soluble bioactive substances in avocado fruits Fruits 68 2013 185 193
20. S.F. Nabavi, M. Daglia, A.H. Moghaddam, S. Habtemariam, and S.M. Nabavi Curcumin and liver disease: from chemistry to medicine Compr. Rev. Food Sci. Food Saf. 13 2014 62 77
21. H. Alinezhad, R. Azimi, M. Zare, M.A. Ebrahimzadeh, S. Eslami, S.F. Nabavi, and S.M. Nabavi Antioxidant and antihemolytic activities of ethanolic extract of flowers, leaves, and stems of Hyssopus officinalis L. var. angustifolius Int. J. Food Prop. 16 2013 1169 1178
22. S.F. Nabavi, S.M. Nabavi, M.A. Ebrahimzadeh, B. Eslami, and N. Jafari In vitro antioxidant and antihemolytic activities of hydroalcoholic extracts of Allium scabriscapum Boiss. & Ky. aerial parts and bulbs Int. J. Food Prop. 16 2013 713 722
23. S.F. Nabavi, S.M. Nabavi, A.H. Moghaddam, A. Naqinezhad, R. Bigdellou, and S. Mohammadzadeh Protective effects of Allium paradoxum against gentamicin-induced nephrotoxicity in mice Food Funct. 3 2012 28 29
24. S.F. Nabavi, G.L. Russo, M. Daglia, and S.M. Nabavi Role of quercetin as an alternative for obesity treatment: you are what you eat! Food Chem. 179 2015 305 310
25. N. Clere, S. Faure, M. Carmen Martinez, and R. Andriantsitohaina Anticancer properties of flavonoids: roles in various stages of carcinogenesis Cardiovasc. Hematol. Agents Med. Chem. 9 2011 62 77
26. S.M. Nabavi, S. Habtemariam, M. Daglia, and S.F. Nabavi Apigenin and breast cancers: from chemistry to medicine Anti Cancer Agents Med. Chem. 2015 10.2174/1871520615666150304120643
27. A.Y. Chen, and Y.C. Chen A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention Food Chem. 138 2013 2099 2107
28. C. Spagnuolo, M. Russo, S. Bilotto, I. Tedesco, B. Laratta, and G.L. Russo Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia Ann. N. Y. Acad. Sci. 1259 2012 95 103
29. I. Orhan, M. Daglia, S.F. Nabavi, M. Loizzo, E. Sobarzo-Sanchez, and S.M. Nabavi Flavonoids and dementia: an update Curr. Med. Chem. 22 2015 1004 1015
30. S.F. Nabavi, M. Daglia, R. Tundis, M. Loizzo, E. Sobarzo-Sánchez, I. Orhan, and S.M. Nabavi Genistein: a boon for mitigating ischemic stroke Curr. Top. Med. Chem. 15 2015 1714 1721
31. J.M. Harnly, R.F. Doherty, G.R. Beecher, J.M. Holden, D.B. Haytowitz, S. Bhagwat, and S. Gebhardt Flavonoid content of US fruits, vegetables, and nuts J. Agric. Food Chem. 54 2006 9966 9977
32. K.C. Ong, and H.E. Khoo Biological effects of myricetin Gen. Pharmacol. 29 1997 121 126
33. S. Habtemariam Catechols and quercetin reduce MTT through iron ions: a possible artefact in cell viability assays Phytother. Res. 9 1995 603 605
34. S. Habtemariam Modulation of tumour necrosis factor-α-induced cytotoxicity by polyphenols Phytother. Res. 11 1997 277 280
35. S. Habtemariam Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-α in L-929 tumor cells J. Nat. Prod. 60 1997 775 778
36. S. Habtemariam, and G.K. Varghese The antidiabetic therapeutic potential of dietary polyphenols Curr. Pharm. Biotechnol. 15 2014 391 400
37. S. Habtemariam Activity-guided isolation and identification of antioxidant components from ethanolic extract of Peltiphyllum peltatum (Torr.) Engl Nat. Prod. Commun. 3 2008 1321 1324
38. S. Habtemariam Activity-guided isolation and identification of free radical-scavenging components from ethanolic extract of boneset (leaves of Eupatorium perfoliatum) Nat. Prod. Commun. 3 2008 1317 1320
39. S. Habtemariam, and R.A. Cowley Antioxidant and anti-α-glucosidase compounds from the rhizome of Peltiphyllum peltatum (Torr.) Engl Phytother. Res. 26 2012 1656 1660
40. M. Roselli, G. Lentini, and S. Habtemariam Phytochemical, antioxidant and anti-α-glucosidase activity evaluations of Bergenia cordifolia Phytother. Res. 26 2012 908 914
41. P. Mladěnka, K. Macáková, T. Filipský, L. Zatloukalová, L. Jahodář, P. Bovicelli, I.P. Silvestri, R. Hrdina, and L. Saso In vitro analysis of iron chelating activity of flavonoids J. Inorg. Biochem. 105 2011 693 701
42. A. GeorgeáPerkin XXI. - Myricetin. Part II J. Chem. Soc. Trans. 81 1902 203 210
43. A. GeorgeáPerkin, and J. JamesáHummel LXXVI. - The colouring principle contained in the bark of Myrica nagi. Part I J. Chem. Soc. Trans. 69 1896 1287 1294
44. A. GeorgeáPerkin VIII. - Notes on some natural colouring matters J. Chem. Soc. Trans. 85 1904 56 64
45. S. Ledda, G. Sanna, G. Manca, M.A. Franco, and A. Porcu Variability in flavonol content of grapes cultivated in two Mediterranean islands (Sardinia and Corsica) J. Food Compos. Anal. 23 2010 580 585
46. K.H. Lee, and E.M. Choi Myricetin, a naturally occurring flavonoid, prevents 2-deoxy-d-ribose induced dysfunction and oxidative damage in osteoblastic MC3T3-E1 cells Eur. J. Pharmacol. 591 2008 1 6
47. H. Wang, and K. Helliwell Determination of flavonols in green and black tea leaves and green tea infusions by high-performance liquid chromatography Food Res. Int. 34 2001 223 227
48. V. Dilis, E. Vasilopoulou, and A. Trichopoulou The flavone, flavonol and flavan-3-ol content of the Greek traditional diet Food Chem. 105 2007 812 821
49. B. Sultana, and F. Anwar Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants Food Chem. 108 2008 879 884
50. Y. Oyama, P.A. Fuchs, N. Katayama, and K. Noda Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca 2 +-loaded brain neurons Brain Res. 635 1994 125 129
51. C. Ozcan, and M. Yaman Determination of myricetin in medicinal plants by high-performance liquid chromatography Instrum. Sci. Technol. 43 2015 44 52
52. Y. Yao, G. Lin, Y. Xie, P. Ma, G. Li, Q. Meng, and T. Wu Preformulation studies of myricetin: a natural antioxidant flavonoid Pharmazie 69 2014 19 26
53. Y. Dang, G. Lin, Y. Xie, J. Duan, P. Ma, G. Li, and G. Ji Quantitative determination of myricetin in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its absolute bioavailability Drug Res. 64 2014 516 522
54. Y. Yao, Y. Xie, C. Hong, G. Li, H. Shen, and G. Ji Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation Carbohydr. Polym. 110 2014 329 337
55. S. Wanga, T. Yea, X. Zhanga, R. Yanga, and X. Yib Myricetin microemulsion for oral drug delivery: formulation optimization, in situ intestinal absorption and in-vivo evaluation Asian J. Pharm. Sci. 8 2013 18 27
56. C. Hong, Y. Dang, G. Lin, Y. Yao, G. Li, G. Ji, H. Shen, and Y. Xie Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation Int. J. Pharm. 477 2014 251 260
57. G. Zdunić, D. Gocrossed d signevac, K. Šavikin, M. Novaković, S. Milosavljević, and S. Petrović Isolation and identification of phenolic compounds from Hypericum richeri Vill. and their antioxidant capacity Nat. Prod. Res. 25 2011 175 187
58. K. Collins, T. Jacks, and N.P. Pavletich The cell cycle and cancer Proc. Natl. Acad. Sci. 94 1997 2776 2778
59. T. Weinert, and D. Lydall Semin. Cancer Biol. 4 1993 129 140
60. S. Negrini, V.G. Gorgoulis, and T.D. Halazonetis Genomic instability - an evolving hallmark of cancer Nat. Rev. Mol. Cell Biol. 11 2010 220 228
61. X.H. Zhang, Z.Q. Zou, C.W. Xu, Y.Z. Shen, and D. Li Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex Mol. Med. Rep. 4 2011 273 277
62. S.J. Elledge Cell cycle checkpoints: preventing an identity crisis Science 274 1996 1664 1672
63. F. Sun, X.Y. Zheng, J. Ye, T.T. Wu, J.L. Wang, and W. Chen Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo Nutr. Cancer 64 2012 599 606
64. D. Maggioni, G. Nicolini, R. Rigolio, L. Biffi, L. Pignataro, R. Gaini, and W. Garavello Myricetin and naringenin inhibit human squamous cell carcinoma proliferation and migration in vitro Nutr. Cancer 66 2014 1257 1267
65. L. Wang, J. Feng, X. Chen, W. Guo, Y. Du, Y. Wang, W. Zang, S. Zhang, and G. Zhao Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo Cancer Cell Int. 14 2014 71
66. J.L. Yi, S. Shi, Y.L. Shen, L. Wang, H.Y. Chen, J. Zhu, and Y. Ding Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines Int. J. Clin. Exp. Pathol. 8 2015 1116
67. P. Roberts, and C. Der Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 26 2007 3291 3310
68. G.S. Martin Cell signaling and cancer Cancer Cell 4 2003 167 174
69. F.G. Giancotti Deregulation of cell signaling in cancer FEBS Lett. 588 2014 2558 2570
70. C. Neuzillet, A. Tijeras-Raballand, L. de Mestier, J. Cros, S. Faivre, and E. Raymond MEK in cancer and cancer therapy Pharmacol. Ther. 141 2014 160 171
71. A.M. Bode, and Z. Dong Signal transduction pathways in cancer development and as targets for cancer prevention Prog. Nucleic Acid Res. Mol. Biol. 79 2005 237 297
72. K.W. Lee, N.J. Kang, E.A. Rogozin, H.G. Kim, Y.Y. Cho, A.M. Bode, H.J. Lee, Y.J. Surh, G.T. Bowden, and Z. Dong Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1 Carcinogenesis 28 2007 1918 1927
73. V. Boudny, and J. Kovarik JAK/STAT signaling pathways and cancer. Janus kinases/signal transducers and activators of transcription Neoplasma 49 2001 349 355
74. T. Kumamoto, M. Fujii, and D.X. Hou Myricetin directly targets JAK1 to inhibit cell transformation Cancer Lett. 275 2009 17 26
75. B.D. Manning, and L.C. Cantley AKT/PKB signaling: navigating downstream Cell 129 2007 1261 1274
76. J.A.F. Vara, E. Casado, J. de Castro, P. Cejas, C. Belda-Iniesta, and M. González-Barón PI3K/Akt signalling pathway and cancer Cancer Treat. Rev. 30 2004 193 204
77. T. Kumamoto, M. Fujii, and D.X. Hou Akt is a direct target for myricetin to inhibit cell transformation Mol. Cell. Biochem. 332 2009 33 41
78. W. Kim, H.J. Yang, H. Youn, Y.J. Yun, K.M. Seong, and B. Youn Myricetin inhibits Akt survival signaling and induces bad-mediated apoptosis in a low dose ultraviolet (UV)-B-irradiated HaCaT human immortalized keratinocytes J. Radiat. Res. 51 2010 285 296
79. P. Phillips, V. Sangwan, D. Borja-Cacho, V. Dudeja, S. Vickers, and A. Saluja Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway Cancer Lett. 308 2011 181 188
80. V. Yadav, and M.F. Denning Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration Mol. Carcinog. 50 5 2011 346 352
81. B. Lewin, A. Siu, C. Baker, D. Dang, R. Schnitt, P. Eisapooran, and D.M. Ramos Expression of Fyn kinase modulates EMT in oral cancer cells Anticancer Res. 30 2010 2591 2596
82. Y.D. Saito, A.R. Jensen, R. Salgia, and E.M. Posadas Fyn: a novel molecular target in cancer Cancer 116 7 2010 1629 1637
83. S.K. Jung, K.W. Lee, S. Byun, N.J. Kang, S.H. Lim, Y.S. Heo, A.M. Bode, G.T. Bowden, H.J. Lee, and Z. Dong Myricetin suppresses UVB-induced skin cancer by targeting Fyn Cancer Res. 68 14 2008 6021 6029
84. S. Elmore Apoptosis: a review of programmed cell death Toxicol. Pathol. 35 2007 495 516
85. S.W. Lowe, and A.W. Lin Apoptosis in cancer Carcinogenesis 21 2000 485 495
86. R. Wong Apoptosis in cancer: from pathogenesis to treatment J. Exp. Clin. Cancer Res. 30 2011 87
87. X.H. Zhang, S.Y. Chen, L. Tang, Y.Z. Shen, L. Luo, C.W. Xu, Q. Liu, and D. Li Myricetin induces apoptosis in Hepg2 cells through Akt/P70s6k/bad signaling and mitochondrial apoptotic pathway Anti Cancer Agents Med. Chem. 13 2013 1575 1581
88. X. Zhang, Y. Ling, H. Yu, and Y. Ji Studies on mechanism of myricetin-induced apoptosis in human hepatocellular carcinoma HepG-2 cells Zhongguo Zhong Yao Za Zhi 35 2010 1046 1050
89. P. Morales, and A.I. Haza Selective apoptotic effects of piceatannol and myricetin in human cancer cells J. Appl. Toxicol. 32 2012 986 993
90. M.E. Kim, T.K. Ha, J.H. Yoon, and J.S. Lee Myricetin induces cell death of human colon cancer cells via BAX/BCL2-dependent pathway Anticancer Res. 34 2014 701 706
91. S. Zhang, L. Wang, H. Liu, G. Zhao, and L. Ming Enhancement of recombinant myricetin on the radiosensitivity of lung cancer A549 and H1299 cells Diagn. Pathol. 9 2014 68
92. M.D. Siegelin, T. Gaiser, A. Habel, and Y. Siegelin Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2 Cancer Lett. 283 2 2009 230 238
93. S. Valastyan, and R.A. Weinberg Tumor metastasis: molecular insights and evolving paradigms Cell 147 2011 275 292
94. S. Moulik, S. Pal, J. Biswas, and A. Chatterjee Role of ERK in modulating MMP 2 and MMP 9 with respect to tumour invasiveness in human cancer cell line MCF-7 and MDA-MB-231 J. Tumor 2 2014
95. Y.W. Shih, P.F. Wu, Y.C. Lee, M.D. Shi, and T.A. Chiang Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: possible mediation by blocking the ERK signaling pathway J. Agric. Food Chem. 57 2009 3490 3499
96. J.D. Kim, L. Liu, W. Guo, and M. Meydani Chemical structure of flavonols in relation to modulation of angiogenesis and immune-endothelial cell adhesion J. Nutr. Biochem. 17 3 2006 165 176
97. S.K. Jung, K.W. Lee, S. Byun, E.J. Lee, J.E. Kim, A.M. Bode, Z. Dong, and H.J. Lee Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo Carcinogenesis 31 5 2010 911 917
98. H. Huang, A.Y. Chen, Y. Rojanasakul, X. Ye, G.O. Rankin, and Y.C. Chen Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis J. Funct. Foods 1 15 2015 464 475